Roche Holding AG (OTCMKTS:RHHBY) Short Interest Down 27.4% in September

Roche Holding AG (OTCMKTS:RHHBY) saw a significant decrease in short interest in the month of September. As of September 30th, there was short interest totalling 2,593,100 shares, a decrease of 27.4% from the September 15th total of 3,574,200 shares. Based on an average trading volume of 2,237,300 shares, the days-to-cover ratio is currently 1.2 days.

Roche Stock Up 0.8 %

OTCMKTS RHHBY opened at $39.18 on Friday. The stock’s 50-day moving average price is $40.01 and its 200-day moving average price is $35.68. Roche has a 52 week low of $29.20 and a 52 week high of $42.43.

Analysts Set New Price Targets

A number of research analysts have weighed in on RHHBY shares. Bank of America raised Roche from a “neutral” rating to a “buy” rating in a report on Friday, September 13th. Deutsche Bank Aktiengesellschaft downgraded Roche from a “hold” rating to a “sell” rating in a research note on Friday, September 13th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. AlphaMark Advisors LLC purchased a new position in Roche in the 1st quarter worth approximately $34,000. GAMMA Investing LLC boosted its position in shares of Roche by 61.5% during the second quarter. GAMMA Investing LLC now owns 5,038 shares of the company’s stock worth $175,000 after acquiring an additional 1,919 shares during the last quarter. Archer Investment Corp boosted its position in shares of Roche by 10.6% during the second quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock worth $236,000 after acquiring an additional 652 shares during the last quarter. Waldron Private Wealth LLC bought a new position in shares of Roche during the second quarter worth $263,000. Finally, Lee Danner & Bass Inc. bought a new position in shares of Roche during the second quarter worth $327,000.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.